PTK2 and pulmonary arterial hypertension: We used ISRIB (integrated stress response inhibitor) as an inhibitor of SG-dependent pathways and found that it inhibited arsenite-induced actin reorganization, as shown by decreased focal adhesions, similar to focal adhesion kinase (FAK) inhibition in PAH-PASMCs [35,36].